To the Editor: Allogeneic hematopoietic siena cell transplantation (aLIo-HSCT) is a curative therapy for patients with acute myelogenous letikemia (A M L) due to the intensive conditioning chemoradiotherapy and t...To the Editor: Allogeneic hematopoietic siena cell transplantation (aLIo-HSCT) is a curative therapy for patients with acute myelogenous letikemia (A M L) due to the intensive conditioning chemoradiotherapy and the effect of graft-versus-leukemia (GVL). An isolated extramedullary (EM) relapse of acute leukemia (AL) is a rare occurrence observed more commonly after allo-HSCT rather than following convemional chemotherapy alone.展开更多
文摘To the Editor: Allogeneic hematopoietic siena cell transplantation (aLIo-HSCT) is a curative therapy for patients with acute myelogenous letikemia (A M L) due to the intensive conditioning chemoradiotherapy and the effect of graft-versus-leukemia (GVL). An isolated extramedullary (EM) relapse of acute leukemia (AL) is a rare occurrence observed more commonly after allo-HSCT rather than following convemional chemotherapy alone.